Clinical Trial

A Study of NWY001 in Subjects With Advanced Solid Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1, single-arm, open-label, dose-escalation study in patients with advanced solid tumors including 2 parts: Part 1: Dose-Escalation Part Part 2: Dose-Expansion Part
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-04; most recent amendment 2024-07-15.
Status change: Not Yet Recruiting → Recruiting 2024-07-15
Trial Details
NCT Number NCT05979155
Lead Sponsor Chipscreen Biosciences, Ltd.
Conditions Advanced Solid Tumor
Enrollment 196 participants
Start Date 2024-01-05
Primary Completion 2026-01 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2024-07-16